First Trust Amex Biotech Index Fund (FBT): Price and Financial Metrics ETF
FBT Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $163.97 | 52-week high | $183.60 |
Prev. close | $163.89 | 52-week low | $141.38 |
Day low | $163.78 | Volume | 13,500 |
Day high | $164.97 | Avg. volume | 22,612 |
50-day MA | $163.52 | Dividend yield | 0.71% |
200-day MA | $0.00 |
FBT Stock Price Chart Interactive Chart >
First Trust Amex Biotech Index Fund (FBT) ETF Bio
The investment objective of the First Trust Amex Biotech Index Fund ETF seeks to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
FBT ETF Info
Issuer | First Trust Portfolios |
Expense Ratio | 0.55% |
Underlying Index | NYSE Arca Biotechnology Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 1.03B |
Net Asset Value (NAV) | $165.58 |
Options? | Yes |
Total Holdings | 32 |
FBT Top Holdings
Symbol | Company | % of Total |
ALNY | Alnylam Pharmaceuticals Inc. | 4.7% |
ARGX | argenx SE (ADR) | 4.08% |
ACAD | ACADIA Pharmaceuticals Inc. | 3.96% |
INCY | Incyte Corporation | 3.88% |
HALO | Halozyme Therapeutics Inc. | 3.7% |
GMAB | Genmab A/S (ADR) | 3.61% |
BMRN | BioMarin Pharmaceutical Inc. | 3.48% |
VCYT | Veracyte Inc. | 3.48% |
UTHR | United Therapeutics Corporation | 3.45% |
FBT Price Returns
1-mo | -1.57% |
3-mo | 2.92% |
6-mo | -4.77% |
1-year | 0.19% |
3-year | 12.49% |
5-year | 3.15% |
YTD | -1.35% |
2024 | 5.88% |
2023 | 2.55% |
2022 | -4.83% |
2021 | -2.26% |
2020 | 12.96% |
FBT Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |